FDA approves expanded labeling for Medtronic's MRI leads

By AuntMinnie.com staff writers

February 18, 2021 -- The U.S. Food and Drug Administration (FDA) has approved expanded labeling for device manufacturer Medtronic's InterStim II and InterStim Micro sacral neuromodulation systems, used with the company's SureScan MRI leads.

The expanded labeling allows for a wider range of MRI scan parameters and shorter wait times between exams, the company said.

Copyright © 2021 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking